Provided by Tiger Fintech (Singapore) Pte. Ltd.

Annovis Bio, Inc.

1.56
-0.0400-2.50%
Volume:118.26K
Turnover:192.09K
Market Cap:30.40M
PE:-0.68
High:1.74
Open:1.62
Low:1.51
Close:1.60
Loading ...
Mar 03, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 28, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 21, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 09, 2020

Major Issues Report

8-K - Current report
Jun 05, 2020

Major Issues Report

8-K - Current report
May 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 20, 2020

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Apr 03, 2020

Major Issues Report

Current report, item 8.01
Mar 25, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Feb 06, 2020

Major Issues Report

Current report, items 5.03 and 9.01
Jan 30, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 24, 2020

Correspondence

[Cover]Correspondence
Jan 24, 2020

Correspondence

[Cover]Correspondence
Jan 24, 2020

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Jan 21, 2020

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933